top of page
Search

EVI joins call for sustained EU investment in global health research ahead of FP10

  • Writer: EVI
    EVI
  • 1 day ago
  • 2 min read

Eight Product Development Partnerships, including the European Vaccine Initiative, have published a joint advocacy paper urging EU Member States to ensure continued and strengthened funding for the Europe & Developing Countries Clinical Trials Partnership (EDCTP) under the 10th EU Framework Programme for Research and Innovation (FP10).

29 June 2026


The paper, Advancing Global Health Innovation Through Europe-Africa Collaboration, makes the case that sustained investment in EDCTP is essential to Europe's health security, scientific leadership, and its ability to remain a credible partner in global health. Co-authored by EVI, DNDi, FIND, GARDP, IAVI, Medicines Development for Global Health, MMV and the TB Alliance, it sets out six concrete recommendations for how the EU can protect and build on more than two decades of prior investment.


Among the case studies illustrating the real-world impact of EDCTP-funded initiatives, the paper features EVI's work through the Malaria Vaccine Pilot Evaluation-Case Control (MVPE-CC) consortium, which generated critical evidence on the four-dose RTS,S schedule under routine immunisation conditions in Ghana, Kenya and Malawi. The project confirmed that four doses provide higher protection against clinical and severe malaria than three in moderate to high transmission settings, findings that were reviewed by WHO advisory bodies and have since informed global vaccination policy.


The six recommendations address: reaffirming EDCTP as the EU's flagship independent global health R&D partnership with a ring-fenced FP10 budget; maintaining its translational research mandate from discovery to licensed products; deepening its focus on access and equity; aligning it within Europe's health security architecture; strengthening long-term Europe-Africa scientific cooperation; and reducing administrative burden for grantees and the programme itself.

As FP10 negotiations advance, EVI and its co-authors call on EU Member States and institutions to recognise EDCTP not merely as a research funding instrument, but as a strategic platform connecting Europe's global health, research and innovation agendas, and one that cannot easily be rebuilt if lost.

 

Read full article:


 
 
bottom of page